Below is the SCOTT Gottlieb Scott Gottlieb Pfizer Commissioner and a former president of the presidential manager.
Margaret Brennan: By the Trump Administration of American Health Policies, we will meet Dr. Scott Gottlieb through a former commissioner, sitting on the Pfizer’s board and now president of Illumina. Good good morning to see you.
Dr. Scott Gottlieb: Good morning.
Margaret Brennan: You know Dr. Gottlieb, you worked in the first Trump Administration. This second Trump Administration is very different in his view of public health. One of them was really naked this week, with this new advice on immunization practices or Aquipari. The Secretary of Kennedy dismissed about 17 members members of the existing committee and some members of his choice. In a video, the President of the American Academy of Pediatrics said that the Federal Immunization Policy, mentioned, is not politicizing “no credible process” and children’s account. That’s a pretty amazing statement. Do you agree with the Pediatric Academy?
Dr. Gottlieb: Look, you’re right. I worked in the first Trump Administration. I was lucky to do this and be proud of that administration. I think we have done a lot of important things in public health. We directed the first cell and gene therapy homologations. The President who tried to expand access to these treatments to test the legislation of the Champion. He helped FDA tobacco products from children’s hands, in an effort to try to have a generic record record and many other achievements. Many people in favor of political publicity I believe that Kennedy’s Secretary General will be a vaccine and will not be a wider blood in a wider public health. I think that’s not well. I think there are many people who are particularly political, or believe that these decisions should be politically decided that vaccines that can go to the doctor’s office or their families life. This looks like a political process right now. Secretary Bugaboos and his Group Against, it will go after children’s health defense. I don’t think it’s sureta at this time. I think he will probably recognize that. That the last 20 years is being champed to limit access to certain vaccines. That will grow. The list is growing and is very tangible to the public and this is, I think most people think when they perceive this administration or when the secretary efforts are perceived, trying to limit access to vaccines.
Margaret Brennan: So one of the specific things in this meeting was advice to avoid flu vaccines. During the same period, CDC removed information from his website. The Secretary of Kennedy said the reporter that darkened the truth. What do people need to know about the flu vaccine and this component?
Dr. Gottlieb: Yes, so it’s an old component. It is mainly conservative used on the floor of the flu vaccine. It only contains a very small percentage of flu vaccines. What is the component that adds to multi-dose containers, as they will be included in various patients who are administered by the vaccine. So there are no single-dose injections. Multi-dose containers are mainly used in certain occupied clinics, right now in adults. In the early 2000s, when I reformed the vaccine in the FDA, so the manufacturers needed to reformulate vaccines to get this preservative. It was not safe because we thought it was, but among the surrounding anti-Vax groups, they thought there was a lot of consternation, there was a link between component and autism. The ingredient has small quantities of ethylmercury, not methylmercury, ethylmercury, the same type of mercury found in fish, in very small numbers. And so the manufacturers were forced to reformulate the vaccine wide majority, four percent of the flu vaccines that are still administered, for most adults, are multi-dose containers. It has long been the Secretary and his group Bugaboo, the essence of children’s health defense. In fact, the only presentation at the ACIP meeting was from the head of that group. And you are right there a study made by CDC officials that has occurred that there is no connection between timerosal and autism. This analysis fell from the website. He said the statement indicated by the Secretary – it was not the right review.
Margaret Brennan: We take a break, Dr. Gottlieb, and talk more about you on the other side. They are complicated issues I want to join you. So we hope you all stay with us.
(Calls)
Margaret Brennan: Welcome to deal with the nation. We will return to our Type of Scott Gottlieb FDA with a common commissioner to our conversation. Dr. Gottlieb, just back up, was talking about the meeting of the rehabilitation committee on the immunization this last week. BILL CASSIDY SENUBRIDE SENUBRIDA, you know, is a doctor. The Health Committee has supervised and has chairs. He called to cancel the meeting because there is no CDC director. As for these denominators, many of them do not experience significant experience in learning microbiology, epidemiology or immunology ‘and they can have’ pre-detection bias’ against MRNA. I’m not a doctor, but it seems to me that you would be an important experience in immunology if you advise immunizations. Here is his advice. Is there a check about Kennedy secretary, at this point? Is there a CDC director to get rapidly?
Dr. Gottlieb: Yes, the CDC director had an assertion this week, and we hope will soon be placed. I think it’s very strong and is a good opportunity for that job. The Council, this ACIP board is not completely formed. Only seven members are on board. At the summit of the partner, it has about 15. And right, many people nominated does not experience deep, nor experience, in vaccine science. In the past they are people aligned with Kennedy secretary and worked with him, many of them, not all. And I think it’s not something that the secretary would discuss at this time and brought some rough moments in that meeting. For example, you know, a member explained the difference between antibody prophylaxis and a vaccine. Therefore, the evidence in this discussion was that the CDC managers had to give some quite remedial support to help these members at the base of the vaccine science. So he showed, we hope that you definitely derive that table completely, you will get more balance. I think some people are skeptical. I hope there will be some good members sitting.
Margaret Brennan: You know, one of the things about the American health system is continuous innovation. Month earlier, FDA injected HIV prevention drug called Lenacapavir twice. How much innovation is like this, and seeing the environment you are talking about, can these new advisors be able to market these types?
Dr. Gottlieb: Yes, this should not come before Aquip. So it is therapeutic. It is a long antiviral action that spent six months against HIV in six months and prevents HIV infection in a population of a high risk of hiring HIV. So it is a change in the formulation of an antiviral that allows you to administer twice a year and provide permanent exposure to the benefits of this antiviral. We are watching many innovations like this. This week, news from a small biotechnology company, have not had any involvement, that they had developed a pill for sustainable anti-flu protection. It is therefore an antiviral, but is formulated in a way that could be administered before the flu season, to provide protection throughout the season, and to be very effective. So we are seeing many innovations like this. What I’m worried is innovation in the sciences of the vaccine. I work in new business investments in new companies, and the start of the biotechnology we wanted to develop new vaccines, such as Epstein-barr virus vaccines, we know it is linked to some of the stymphomas of cells with multiple sclerosis. That is, the new field of science, the ability to insert children against it, as we insert children against HPV, right now and we avoid other types of cervical cancer and other cancer. In the future, we can have vaccination for EBV, but many shots have been made for this type of investment. So I think we will see less innovation in vaccine science.
Margaret Brennan: Quickly, the Secretary of Kennedy was asked this week to start removing fluoride from some states. Oklahoma moved that direction. He said he would see “probably slightly more cavities”, but there is a direct correlation between the number of fluoride and IQ loss in your waters. ‘ What should parents think when they hear things like this?
Dr. Gottlieb: Look, it looked long. The Secretary of Kennedy has been champion in his career, which is perceived between fluoride and water and its neurotoxic effects. This has been well studied. I think, completely forbidden. There are very small amounts of fluoride in water, and in the levels that enter water supply, it is proven to be safe. CDC’S- comes with data, reducing 25% of toothparts as a result of fluoride that is added to the water supply. It is not the question of large dental cavities, as well as general oral health in general, that we know is related to systemic health.
Margaret Brennan: Dr. Gottlieb to get your view today. We will go back.
